Answers are grounded in this paper and cite their sources.
Demonstrates reduced senescence and inflammatory signaling in oral fibroblasts, suggesting therapeutic potential.
Background Cigarette smoke exposure is a major risk factor for oral cancer, partly due to its ability to induce early molecular alterations in the oral mucosa. Cellular senescence and the senescence-associated secretory phenotype (SASP) contribute to chronic inflammation and microenvironmental remodeling, favoring carcinogenesis. The PI3K/AKT/mTOR pathway has been implicated in sustaining SASP and senescence, suggesting that its inhibition may represent a promising preventive strategy. Methods Primary human oral fibroblasts (hOF) and a 3D oral mucosa model were exposed to cigarette smoke extract (CSE) 2% for 72 h, with or without pre-treatment with the dual pan–class I PI3K/mTOR inhibitor PKI402 (10 −7 -10 −9 M). Senescence markers (p21, p16, lamin B1) were quantified by RT-qPCR; SASP cytokines (IL-6, IL-8) by ELISA; DNA damage by γH2AX immunofluorescence; and senescence-associated β-galactosidase (SA-β-gal) activity by flow cytometry. Results CSE exposure induced a senescent phenotype characterized by increased p21 and p16, decreased lamin B1, elevated IL-6 and IL-8 secretion, accumulation of γH2AX foci, and enhanced SA-β-gal activity. PKI402 significantly attenuated these changes in a dose-dependent manner, with the highest concentrations showing statistically significant reductions across all endpoints. Conclusion Pharmacological inhibition of PI3K/mTOR mitigates cigarette smoke-induced senescence and SASP in oral fibroblasts, reducing DNA damage and inflammatory signaling. These findings highlight PI3K/mTOR pathway as a potential target for senomorphic interventions aimed at preventing pro-tumorigenic microenvironment remodeling in oral carcinogenesis.
No takes yet. Share an insight, caveat, or question.
Flacco et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: